Literature DB >> 20856158

MicroRNA-21 overexpression contributes to vestibular schwannoma cell proliferation and survival.

Joseph A Cioffi1, Wei Ying Yue, Sabrina Mendolia-Loffredo, Kameron R Hansen, P Ashley Wackym, Marlan R Hansen.   

Abstract

HYPOTHESIS: Elevated levels of hsa-microRNA-21 (miR-21) in vestibular schwannomas (VSs) may contribute to tumor growth by downregulating the tumor suppressor phosphatase and tensin homolog (PTEN) and consequent hyperactivation of protein kinase B (AKT), a key signaling protein in the cellular pathways that lead to tumor growth.
BACKGROUND: Vestibular schwannomas are benign tumors that arise from the vestibular nerve. Left untreated, VSs can result in hearing loss, tinnitus, vestibular dysfunction, trigeminal nerve dysfunction, and can even become life threatening. Despite efforts to characterize the VS transcriptome, the molecular pathways that lead to tumorigenesis are not completely understood. MicroRNAs are small RNA molecules that regulate gene expression posttranscriptionally by blocking the production of specific target proteins.
METHODS: We examined miR-21 expression in VSs. To determine the functional significance of miR-21 expression in VS cells, we transfected primary human VS cultures with anti-miR-21 or control, scrambled oligonucleotides.
RESULTS: We found consistent overexpression of miR-21 when compared with normal vestibular nerve tissue. Furthermore, elevated levels of miR-21 correlated with decreased levels of PTEN, a known molecular target of miR-21. Anti-miR-21 decreased VS cell proliferation in response to platelet-derived growth factor stimulation and increased apoptosis, suggesting that increased miR-21 levels contributes to VS growth.
CONCLUSION: Because PTEN regulates signaling through the growth-promoting phosphoinositide 3-kinase/AKT pathway, our findings suggest that miR-21 may be a suitable molecular target for therapies aimed specifically at reducing VS growth.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20856158      PMCID: PMC2978772          DOI: 10.1097/MAO.0b013e3181f20655

Source DB:  PubMed          Journal:  Otol Neurotol        ISSN: 1531-7129            Impact factor:   2.311


  37 in total

Review 1.  The multiple roles of PTEN in tumor suppression.

Authors:  A Di Cristofano; P P Pandolfi
Journal:  Cell       Date:  2000-02-18       Impact factor: 41.582

2.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

3.  Expression of mRNAs for ciliary neurotrophic factor (CNTF), leukemia inhibitory factor (LIF), interleukin-6 (IL-6), and their receptors (CNTFR alpha, LIFR beta, IL-6R alpha, and gp130) in human peripheral neuropathies.

Authors:  Y Ito; M Yamamoto; N Mitsuma; M Li; N Hattori; G Sobue
Journal:  Neurochem Res       Date:  2001-01       Impact factor: 3.996

Review 4.  The roles of microRNAs in heart diseases: a novel important regulator.

Authors:  B Cai; Z Pan; Y Lu
Journal:  Curr Med Chem       Date:  2010       Impact factor: 4.530

5.  MicroRNA expression in response to murine myocardial infarction: miR-21 regulates fibroblast metalloprotease-2 via phosphatase and tensin homologue.

Authors:  Sashwati Roy; Savita Khanna; Syed-Rehan A Hussain; Sabyasachi Biswas; Ali Azad; Cameron Rink; Surya Gnyawali; Shani Shilo; Gerard J Nuovo; Chandan K Sen
Journal:  Cardiovasc Res       Date:  2009-01-15       Impact factor: 10.787

6.  Audiologic and radiographic response of NF2-related vestibular schwannoma to erlotinib therapy.

Authors:  Scott R Plotkin; Marybeth A Singh; Caroline C O'Donnell; Gordon J Harris; Andrea I McClatchey; Chris Halpin
Journal:  Nat Clin Pract Oncol       Date:  2008-06-17

7.  Neurofibromatosis 2 (NF2) tumor suppressor schwannomin and its interacting protein HRS regulate STAT signaling.

Authors:  Daniel R Scoles; Vu D Nguyen; Yun Qin; Chun-Xiao Sun; Helen Morrison; David H Gutmann; Stefan-M Pulst
Journal:  Hum Mol Genet       Date:  2002-12-01       Impact factor: 6.150

8.  Dissecting and targeting the growth factor-dependent and growth factor-independent extracellular signal-regulated kinase pathway in human schwannoma.

Authors:  Sylwia Ammoun; Christine Flaiz; Natalia Ristic; Jennifer Schuldt; C Oliver Hanemann
Journal:  Cancer Res       Date:  2008-07-01       Impact factor: 12.701

9.  Targeting ERK1/2 activation and proliferation in human primary schwannoma cells with MEK1/2 inhibitor AZD6244.

Authors:  Sylwia Ammoun; Natalia Ristic; Cordula Matthies; David A Hilton; C Oliver Hanemann
Journal:  Neurobiol Dis       Date:  2009-10-03       Impact factor: 5.996

10.  Identification of miR-21 targets in breast cancer cells using a quantitative proteomic approach.

Authors:  Yi Yang; Raghothama Chaerkady; Michael A Beer; Joshua T Mendell; Akhilesh Pandey
Journal:  Proteomics       Date:  2009-03       Impact factor: 3.984

View more
  27 in total

Review 1.  MicroRNAs: effective elements in ear-related diseases and hearing loss.

Authors:  Mohammad-Reza Mahmoudian-Sani; Ameneh Mehri-Ghahfarrokhi; Fereshteh Ahmadinejad; Morteza Hashemzadeh-Chaleshtori; Massoud Saidijam; Mohammad-Saeid Jami
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-02-21       Impact factor: 2.503

Review 2.  Non-coding RNAs in the development of sensory organs and related diseases.

Authors:  Ivan Conte; Sandro Banfi; Paola Bovolenta
Journal:  Cell Mol Life Sci       Date:  2013-04-16       Impact factor: 9.261

3.  Understanding Molecular Evolution and Development of the Organ of Corti Can Provide Clues for Hearing Restoration.

Authors:  Israt Jahan; Karen L Elliott; Bernd Fritzsch
Journal:  Integr Comp Biol       Date:  2018-08-01       Impact factor: 3.326

4.  Preclinical validation of anti-nuclear factor-kappa B therapy to inhibit human vestibular schwannoma growth.

Authors:  Sonam Dilwali; Martijn C Briët; Shyan-Yuan Kao; Takeshi Fujita; Lukas D Landegger; Michael P Platt; Konstantina M Stankovic
Journal:  Mol Oncol       Date:  2015-03-31       Impact factor: 6.603

5.  MicroRNA profiling in pediatric pilocytic astrocytoma reveals biologically relevant targets, including PBX3, NFIB, and METAP2.

Authors:  Cheng-Ying Ho; Eli Bar; Caterina Giannini; Luigi Marchionni; Matthias A Karajannis; David Zagzag; David H Gutmann; Charles G Eberhart; Fausto J Rodriguez
Journal:  Neuro Oncol       Date:  2012-11-15       Impact factor: 12.300

6.  A Unified Methodological Framework for Vestibular Schwannoma Research.

Authors:  Lukas D Landegger; Jessica E Sagers; Sonam Dilwali; Takeshi Fujita; Mehmet I Sahin; Konstantina M Stankovic
Journal:  J Vis Exp       Date:  2017-06-20       Impact factor: 1.355

7.  Contribution of persistent C-Jun N-terminal kinase activity to the survival of human vestibular schwannoma cells by suppression of accumulation of mitochondrial superoxides.

Authors:  Wei Ying Yue; J Jason Clark; Augusta Fernando; Frederick Domann; Marlan R Hansen
Journal:  Neuro Oncol       Date:  2011-06-22       Impact factor: 12.300

8.  Association of microRNA 146 with middle ear hyperplasia in pediatric otitis media.

Authors:  Tina L Samuels; Justin Yan; Pawjai Khampang; Alexander MacKinnon; Wenzhou Hong; Nikki Johnston; Joseph E Kerschner
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2016-07-02       Impact factor: 1.675

Review 9.  MicroRNA-mediated gene regulations in human sarcomas.

Authors:  Subbaya Subramanian; Reena V Kartha
Journal:  Cell Mol Life Sci       Date:  2012-08-25       Impact factor: 9.261

10.  Primary culture of human Schwann and schwannoma cells: improved and simplified protocol.

Authors:  Sonam Dilwali; Pratik B Patel; Daniel S Roberts; Gina M Basinsky; Gordon J Harris; Kevin S Emerick; Konstantina M Stankovic
Journal:  Hear Res       Date:  2014-06-06       Impact factor: 3.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.